(ZHE) Every year, the world’s richest and most powerful business executives, bankers, media heads and politicians sit down in some luxurious and heavily guarded venue, and discuss how to shape the world in a way that maximizes profits for all involved, while perpetuating a status quo that has been highly beneficial for a select few, even if it means the ongoing destruction of the middle class.
In a new study looking at the effects of a Mediterranean diet on people with poor heart health, the popular diet appeared to help heart patients more than statin drugs.
U.S. regulators in July of 2016 halted a trial of Juno Therapeutics Inc.’s experimental cancer therapy, known as JCAR015, after three patients died.
JCAR015 uses genetically engineered cells as a treatment for cancer. However, one of the pursuits in oncology was temporarily halted by the FDA when some of the participants developed fatal swelling in the brain.
Hans Bishop, Juno’s chief executive, said in a conference call with securities analysts that the deaths were “difficult and humbling for everyone involved.”
